The Generalized Pólya Urn (GPU) is a popular urn model which is widely used in many disciplines. In particular, it is extensively used in treatment allocation schemes in clinical trials. In this paper, we propose a sequential estimation-adjusted urn model (a nonhomogeneous GPU) which has a wide spectrum of applications. Because the proposed urn model depends on sequential estimations of unknown parameters, the derivation of asymptotic properties is mathematically intricate and the corresponding results are unavailable in the literature. We overcome these hurdles and establish the strong consistency and asymptotic normality for both the patient allocation and the estimators of unknown parameters, under some widely satisfied conditions. These properties are important for statistical inferences and they are also useful for the understanding of the urn limiting process. A superior feature of our proposed model is its capability to yield limiting treatment proportions according to any desired allocation target. The applicability of our model is illustrated with a number of examples.
1. Introduction.
Brief history.
Urn models have long been recognized as valuable mathematical apparatus in many areas including physical sciences, biological sciences and engineering [19, 20] . Among various urn models, the Pólya urn urn composition at the previous stage. That is, if the nth draw is a type-k particle, all elements in X n are 0 except the kth component X n,k which is 1. Moreover, define H i = (E[d i (k, g, ξ i,k )|F i−1 ], k, q = 1, . . . , K), where the sigma field F i is generated by {Y 0 , Y 1 , . . . , Y i , X 1 , . . . , X i }. The matrices D i and H i are called the addition rules and the generating matrices, respectively. These matrices play important roles in the mechanism of the GPU model.
A GFU model is said to be homogeneous if H i = H for all i = 1, . . . , n. For instance, if the addition rule D i is merely a function of the ith patient's observed outcome, the addition rules are independent and identically distributed (i.i.d.). Consequently H i = H = ED i are identical and nonrandom. However, in clinical studies, the entire history of all previous trials provides more information of the efficacies of the treatments. For applications of such models, one can refer to Andersen, Faries and Tamura [1] and Bai, Hu and Shen [6] . If the addition rules rely on all the previous outcomes, the GPU model is no longer homogeneous. Under these circumstances, we will only assume that H n converges to a limit H.
In clinical investigations, a crucial element of the treatment allocation process is the number of patients being assigned to a particular treatment. Here, we define N n = (N n,1 , . . . , N n,K ). The quantity N n,k is the number of times a type-k particle is selected in the first n stages. In clinical trials, N n,k represents the number of patients assigned to treatment k among the first n patients. Obviously,
Owing to its clinical applications, the asymptotic behavior of N n is of immense importance [15] . Athreya and Karlin [2, 3] obtained the asymptotic convergence of Y n and N n and conjecture that N n is asymptotically normal. This conjecture has not been solved for almost three decades due to its mathematical complexity. A limited success was reported by Smythe [27] who derived the asymptotic normality of Y n and N n under the assumptions that the eigenvalues of the generating matrix H are simple and the GPU is homogeneous. Bai, Hu and Zhang [7] considered functional limit theorems of Y n and N n for K = 2. Further, Janson [17] established functional limit theorems of Y n and N n for the general homogeneous GPU model and the asymptotic normality of N n follows.
1.2.
Objectives and organization of the paper. Recently, Bai and Hu [5] established the consistency and the asymptotic normality of the GPU nonhomogeneous model. However, their theorems rely on very stringent assumptions which are not valid in many practical applications (illustrated in Section 2). In this paper, we derive a sequential estimation-adjusted urn model (SEU) and successfully produce important asymptotic theorems related to Y n and N n . Our allocation scheme is suitable for many popular clinical scenarios. Because the proposed urn model depends on sequential estimators of unknown parameters, we cannot use the techniques of Bai and Hu [5] to show the asymptotic properties. Instead, we show the law of the iterated logarithm of the estimators first and then prove the strong consistency and asymptotic normality of the SEUs by using the results of the law of the iterated logarithm. Also we obtain the asymptotic properties of the estimators of unknown parameters.
Another important advantage of our proposed SEU model is that it can be used to satisfy a pre-specified treatment allocation target. Different targets might be of interest in clinical studies [25] . In fact, there is a growing interest in target-based designs which are derived with a pre-specified allocation target (see, e.g., [11, 12, 16, 22, 23] ). Based on some optimality consideration, a suitable allocation target, say v, is used. It will be shown later that we are able to define an SEU model to ensure that the allocation proportion converges to v almost surely. Illustrative examples are given in Section 4.
To summarize, the major contributions of this paper are:
(a) to propose a general nonhomogeneous GPU model (SEU) with the addition rules utilizing sequential estimations of unknown parameters; (b) to show strong consistency and asymptotic normality of N n under widely satisfied conditions and obtain a general and explicit asymptotic variance of N n ; (c) to state the framework of the targeting procedures of SEU when the desired allocation proportion is pre-specified based on some optimality consideration; and (d) to illustrate with examples the applications of the SEU model in clinical trials.
The SEU model will be described in Section 2. Asymptotic properties are presented in Section 3. Then in Section 4, selected examples are provided to illustrate the application of the SEU model in clinical trials. Concluding remarks are also given. Finally, technical proofs are stated in Section 5.
2. Sequential estimation-adjusted urn model.
2.1.
The SEU process. Before the outline of the SEU model, we adopt the following assumption on patient responses. Let the responses {{ξ j,k , j = 1, 2, . . .}, k = 1, . . . , K} be K independent sequences of i.i.d. random variables, and write ξ j = (ξ j,1 , . . . , ξ j,K ). In clinical trial, ξ i,k can only be observed when the ith patient is assigned to treatment k, that is, when X i,k = 1. Now, a useful nonhomogeneous GPU model with addition rules utilizing the entire history of the previous trials is given as follows.
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The SEU process. Let Θ = (θ 1 , . . . , θ K ) be the parameter from the distribution of the response ξ n = (ξ n,1 , . . . , ξ n,K ). If the value of Θ is known, it is natural to consider the adaptive design with addition rules D(Θ, ξ n ) and generating matrices H = H(Θ) = E[D(Θ, ξ n )], whose values depend on the parameter Θ. Here, the d × d matrix H(x) is a function continuous at point Θ, and also, as a function of x, the matrix D(x, y) = {D ij (x, y)} is continuous at point Θ for any fixed possible value y of ξ n . However, Θ is usually unknown in practice; an estimate of Θ is therefore required. Hence, without loss of generality, we assume Θ = E[ξ n ], with its estimate Θ n = (θ n,1 , . . . ,θ n,K ),
Here, adding 1 to both the numerator and the denominator is only to avoid the nonsense case of 0/0. We consider the adaptive design with adding rules D n = D( Θ n−1 , ξ n ) and generating matrices
The above SEU model has generating matrices H n that are not homogeneous. Bai and Hu [4, 5] established the consistency and asymptotic normality of centered urn compositions Y n − EY n for a wide spectrum of urn models with generating matrices H n satisfying the condition that
Here · denotes the norm of a matrix or a vector. This condition is in general true for practical applications and it is true for the SEU model. Now, let us turn to the asymptotic property of N n that is more useful but intricate. Janson [17] gave a general result of the limiting distribution of N n for homogeneous urn models (cf. his Theorem 3.28). The basic technique of Janson [17] is to embed the urn process in a continuous-time branching process. The embedding technique was developed by Athreya and Karlin [3] . Unfortunately, this method does not work for nonhomogeneous urns. The very recent work of Bai and Hu [5] established the asymptotic normality of N n − EN n for nonhomogeneous urn models when the generating matrices H n satisfy condition (2.1) as well as the following condition:
It is beyond doubt that the asymptotic distributions of Y n and N n with the centralization factors EY n and EN n being substituted by nv are more realistic, because the values EY n and EN n are both unknown and computing them is far too complex, if not infeasible. To provide a possible solution, Bai and Hu [5] suggested that EY n and EN n can be replaced by nv if condition (2.1) is revised to a more stringent condition: 
as indicated in Bai and Hu [5] . In fact, conditions (2.2) and (2.3) are not satisfied with the SEU model because the fastest almost sure convergence rate of H n − H is O( (log log n)/n ) according to the law of the iterated logarithm and the fastest L 2 convergence rate is O( √ n ) according to the central limit theorem. So, the general theorems of Bai and Hu [5] do not apply here.
2.2.
Targeting pre-specified limiting allocation proportions. As explained in the Introduction, it is frequent that desired limiting allocation proportions are given and our SEU model has the ability to target these proportions. First, let us state the well-known results related to the convergence of N n and the generating matrix H (see, e.g., [4, 5, 17] ). Under suitable conditions the allocation proportion converges to a limit, that is,
where v = (v 1 , . . . , v K ) is the left eigenvector of the (limiting) generating matrix H with respect to its largest eigenvalue and satisfying
To target a pre-specified allocation proportion, one needs to define the SEU process in such a way to force the sample allocation proportion to the desired one as a limit. To illustrate, we will take the two-treatment case with binary responses as an example.
For a binary response (success and failure) clinical trial with two treatments (1 and 2), Rosenberger et al. [26] proposed the following allocation proportion (called the optimal allocation proportion) by considering simultaneously the statistical testing power for comparing the two treatments and the failure rate of patients undergoing the two treatments,
Other allocation proportions and a general procedure to find an allocation proportion according to an optimization criterion had been discussed by Jennison and Turnbull [18] . When the SEU model is used to target the above
proportion, we need to define an urn model such that v = (
) is the eigenvector of its generating matrix H with respect to the largest eigenvalue. Assume that the expectation of total number of balls added at each stage is the same, say γ. Then H can be written in the following form:
According to (2.5), we have
One simple solution of the above equation is α = √ p 2 and β = √ p 1 . Another obvious solution is α = v 2 and β = v 1 . In either case, the generating matrix is a function of p 1 and p 2 . If p 1 and p 2 are known, to implement the allocation proportion, we can define an SEU model with addition rules
Further, when p 1 and p 2 are unknown, their estimates will be employed as instructed in the previous subsection. Examples are provided in Section 4.
3. Asymptotic properties. In this section we will study the asymptotic properties for our SEU model. Major theorems will be given with proofs stated in the last section. Owing to the use of estimates of the unknown parameters, one will discover that the asymptotic variance is different from that given in [5] and [17] and the mathematical techniques are much more complex.
Recall that Y n and N n are defined by (1.1) and (1.2) and
To study the asymptotic properties of Y n and N n , the following assumptions are required. Assumption 3.1. We assume that H1 ′ = γ1 ′ , where γ > 0 and 1 = (1, . . . , 1). Suppose H has the following Jordan decomposition:
where J s is a ν t × ν t matrix, given by
Without loss of generality, we assume that γ = 1. Otherwise, we can consider Y n /γ and D n /γ, instead. Let v be the left eigenvector of H corresponding to its maximal eigenvalue 1 with v1 ′ = 1 ′ . We may select the matrix T so that its first column is 1 ′ and the first row of T −1 is v. Let λ = max{Re(λ 2 ), . . . , Re(λ s )} and ν = max j {ν j : Re(λ j ) = λ}. Assumption 3.2. For the addition rules D n = D( Θ n−1 , ξ n ) and the responses ξ n , suppose D ij (x, y) ≥ 0 is continuous at point (Θ, y 0 ) for each y 0 and there is an r > 2 such that E ξ 1 r < ∞ and
Assumption 3.4. For the function H(x), there is a δ > 0 such that
Using the above notation, we shall establish the following results.
Theorem 3.1. For the SEU, suppose that Assumption 3.1 is satisfied. If λ < 1, and Assumption 3.2 is satisfied for some r > 1, then 
where N (0, Λ † ) and N (0, Λ ♯ ) are the normal distributions in R K with mean zero and K × K variance-covariance matrices Λ † and Λ ♯ , which will be specified by (5.24) and (5.26), respectively. 
The next corollary provides results on a special case of SEU.
) be a vector function being twice differentiable at Θ and ρ k (x) > 0, h = 1, . . . , K. Consider an adaptive design with addition rules D n = 1 ′ ρ( Θ n−1 ), that is, ρ k ( Θ n−1 ) balls of type k are added to the urn at stage n, k = 1, . . . , K, where Θ n−1 is the sample estimate of Θ which is defined as in SEU. Then
. Here
4. Applications and conclusions. In this section we give some motivating examples in order to show the applicability of our SEU model. The first one is related to allocation schemes which aim at assigning more patients to the better treatment. The remaining two are connected to designs with focus on desired targets.
Example 1 ([6]
). Consider a K-treatment clinical trial with binary responses. Let p k be the success probability of a patient on treatment k, and let q k = 1 − p k be the failure probability, k = 1, . . . , K. Bai, Hu and Shen [6] (BHS Adaptive Design) proposed to add particles proportional to the estimated success rates for other K − 1 treatments, when the response is a failure on treatment k, that is, at the nth stage, a success on treatment k generates a particle of type k, and a failure on treatment k generateŝ
N n−1,j +1 , and S n−1,j denotes the number of successes of treatment j in all the N n−1,j trials of the previous n − 1 stages, j = 1, . . . , K. They established the strong consistency of Y n and N n of this model. For this design,
for k = j. Using Theorem 3.3, we can get the asymptotic normalities.
Example 2. We consider a two-treatment clinical trial with binary responses. Suppose that we want to target the optimal allocation proportion proposed by Rosenberger et al. [26] . In (2.6), we choose α = √ p 2 , β = √ p 1
The design is defined as follows. At the nth stage, no matter what the response of the nth patient is, we add √p n−1,1 particles of type 1 and √p n−1,2 particles of type 2 to the urn. If 0 < p 1 , p 2 < 1, then
It can be verified that
and
where
Example 3. We consider a two-treatment clinical trial with binary responses. Suppose that we want to target the allocation proportion (
) of the randomized play-the-winner (RPW) rule proposed by Wei and Durham [31] . In (2.6) we choose α = v 2 , β = v 1 and γ = 1. particles of type 2 to the urn, wherê
The asymptotic variances are much smaller than those given by the RPW rule when q 1 + q 2 is near or less than 1/2, since when q 1 + q 2 > 1/2, the asymptotic variances of Y n,1 /n and N n,1 /n in the RPW rule are
respectively (cf. [28] ). When q 1 + q 2 < 1/2, the limiting distributions of Y n and N n in the RPW rule are unknown, and the convergence rates of the variances are much slower. But, for the adaptive design given here, the asymptotic normality can be evaluated according to our formula for any 0 < q 1 , q 2 < 1.
Examples 2 and 3 demonstrate the ability of the SEU model to target a given allocation proportion. In general, we can use Corollary 3.2 to target any desired allocation proportion. This is a useful property of our proposed model.
The examples in this section provide illustrations of how the proposed techniques are translated into applications in the formulation of valuable treatment allocation schemes. We can also evaluate these schemes by reviewing the respective asymptotic properties of Y n and N n .
The main contributions of this paper are in proposing the family of sequential estimation-adjusted urn models and showing the two important properties of the SEU models: (i) they can be used to target any given allocation proportions, and (ii) they have certain desired asymptotic properties under some widely satisfied conditions. Based on the asymptotic results, we are able to derive new designs which have smaller variabilities than some traditional and popular urn models (see Example 3) .
In this paper we considered the application of the SEU models in clinical trials. The idea of using constantly updated estimators in SEU models is novel and the SEU models can be employed in other areas. In fact, there are abundant urn model applications where data are collected sequentially and the consecutive estimations of unknown parameters provide better solutions to the formulated problem.
For simplicity, the examples considered in this section are all binary responses. However, the SEU models can be applied to different types of responses. From the definition of the SEU process, the response ξ n could be discrete or continuous. For example, we can apply the SEU model to the case studied in Section 8 of [12] . In that case, the response is normally distributed and the target proportion is the Neyman allocation. Generally, the assumptions in Section 3 are satisfied if the third moments of ξ and D exist and the function H is differentiable. Therefore, the SEU model has a wide spectrum of applications.
Proofs. First, we state several relevant lemmas. Recall
Lemma 5.1. Let B n,n = I and B n,i = n j=i+1 (I + j −1 H). If two sequences of matrices Q n and P n satisfy Q 0 = P 0 = 0 and
that is,
where ∆P n = P n − P n−1 is the difference of P n , then
where log x = ln(x ∨ e) hereafter.
Proof. See Lemma A.1 of [16] .
Lemma 5.2. For the SEU, if Assumption 3.2 is satisfied with some
} is a sequence of martingale differences with 
by condition (3.1). According to the law of large numbers of martingales (cf. [14] ),
which, together with the generalized Borel-Cantelli lemmas, implies that P(X n,k = 1, i.o.) = 1. Then N n,k → ∞ a.s., k = 1, . . . , K. By Lemma A.4 of [16] again, the lemma is proved. Now, let |Y n | = Y n 1 ′ be the total number of balls in the urn at the nth stage, and let M n = n k=1 ∆M k and m n = n k=1 ∆m k , where
n ≥ 1} is a martingale sequence. By (1.1),
Note that v1 ′ v = v and vH = 0. By (5.4), it follows that
Also by (1.2),
Proof of Theorem 3.1. First, note that r > 1, ∆m n ≤ 2, and according to (3.1),
By the strong law of large numbers of martingales, we have
On the other hand, by Lemma 5.2 and the continuity of H(x), we have
a.s. 
which, together with (5.5) and (5.9), implies that
Now, by combining (5.6), (5.10) and (5.12) it follows that
which, together with (5.5) and (5.9), yields
And then by Lemma 5.1, we conclude that
Finally, from (5.7) it follows that
The proof of Theorem 3.1 is complete.
To prove Theorem 3.2, we need the following lemma.
Lemma 5.3. Under the assumptions in Theorem 3.2, we have
Proof. Note that by Theorem 3.1,
So, by Lemma 5.2,
The proof is then complete by noting Assumption 3.3.
Proof of Theorem 3.2. First, note that ∆m n ≤ 2, (5.8) and r > 2. By the law of the iterated logarithm of martingales, we have M n = O( n log log n ) and m n = O( n log log n ) a.s. 
= O( n log log n ), which, together with (5.5), implies that
And then from (5.6), it follows that
= O( n log log n ).
With (5.5) and (5.13), we conclude that
which, together with Lemma 5.1, implies that 
Theorem 3.2 is proved.
Proof of Theorem 3.3. Without loss of generality, we assume that δ is small enough such that δ < 1/2 − λ. Define
and Q n = (Q n,1 , . . . , Q n,K ) = n m=1 ∆Q m , where ∆Q m = X m diag(ξ m − Θ). Then Q n is a martingale since ξ m is independent of X m and the σ-field F m−1 . By Lemma 5.3 and Assumption 3.4,
It follows that
Now, from (5.6), (5.17), Theorem 3.2 and Lemma 5.3 it follows that
So, by (5.5),
Let U 0 = 0 and
By Lemma 5.1, it follows that
On the other hand, by (5.2),
Also, by (5.7) and Theorem 3.2,
So, to show the asymptotic normalities of Y n and N n , it suffices to show the asymptotic normalities of U n and V n . Write B
(1)
n,m = n−1 i=m
Note that U n and V n are sums of martingale differences. We will use the central limit theorem for martingale (cf. [14] ) to prove our result. According to (5.8), that is, the Lindberg condition is satisfied. Finally, it is enough to calculate the asymptotic (conditioned) variance-covariance matrices of U n and 
By noting (5.21), HB n,m = B n,m H and
we can write
n,m H + I)
n,m ,
n,m .
SEQUENTIAL ESTIMATION-ADJUSTED URN MODELS
23
Then by (5.23),
where a H is defined to be e H ln a = ∞ j=0
Here we use Var(·|) to denote the sum of conditional variance-covariance matrices of related martingale differences, and Cov{·, ·|} is defined similarly. Also,
n , U
n |} = 0 a.s. n , U
Note that a H ≤ Ca λ log ν−1 a for a ≥ 1. The above integrals are well defined. It follows that
And then by the central limit theorem for martingales (cf. [14] )
n |} = o(n) a.s., Cov{V
n |} = 0 a.s.
and Cov{V (2) n , V
n |}
It follows that
And then by the central limit theorem for martingales (cf. [14] ), Proof of Corollary 3.1.
On the other hand,
Finally, notice that ρ(x) = ρ(x)1 ′ v(x). We have
The proof is now complete.
Remark 5.1. One can also show that n −1 Cov{U n , V n |} → Λ †♯ a.s. for some Λ †♯ . So,
Actually, with a more careful but complex proof similar to that in [16] This shows that the joint distribution of n 1/2 ( Θ n − Θ), n 1/2 (Y n /n − v) and n 1/2 (N n /n − v) converges to a mean-zero 3K-dimensional Gaussian distribution. If λ = 1/2, one also can show that (5.22) holds with (n log 2ν−1 n) 1+δ/2 replacing n r/2 , and that (n log 2ν−1 n) −1 Var{(U n , V n )|} converges to a 2d × 2d matrix. This implies that the asymptotic normalities of Y n and N n also hold. 
where [T * g Σ 2 T h ] a ′ ,b ′ is the (a ′ , b ′ )-element of the matrix [T * g Σ 2 T h ].
